Упрощенная HTML-версия
136
73. Ahkee S. Community-acquired pneumonia in the elderly: association of
mortality with lack of fever and leukocytosis / S. Ahkee, L. Srinath, J. Ramirez //
Southern Med. J. - 1997.
74.
Guideline 'Diagnosis and treatment of community-acquired
pneumonia' from the Dutch Thoracic Society / R.M.
W.G.
//
– 2005. – Vol. 149, № 45. – P.
2501-2507.
75.
Ambulatory management of community acquired pneumonia in the elderly / P.
et al.] //
– 2006. – Vol. 134, № 12. – P. 1568-1575.
76. A multicenter, randomized, double-blind, retrospective comparison of 5- and
10-day regimens of levofloxacin in a subgroup of patients aged > or =65 years with
community-acquired pneumonia / A.F.
et al.] //
– 2005. – Vol. 27,
№ 8. – P. 1251-1259.
77. Analysis of factors affecting prolonged hospitalizations in elderly patients with
community-acquired pneumonia / M.T.
et al.] //
– 2004. – Vol. 41, № 6. – P. 666-669.
78. Bartlett J.G. Practice guidelines for the management of community- acquired
pneumonia in adults / J.G. Bartlett, S.F. Dowell, L.A. Mandell // Clin. Infect. Dis. –
2000. - № 31. – P. 347-382.
79. Betterige D.J. What is oxidative stress? / D.J. Betterige // Metabolism. – 2000.
– Vol. 49. – Suppl. 1. – P. 3-8.
80. British Thoracic Society Guidelines for the management of community-
acquired pneumonia in adults // Thorax. – 2001. - № 56(suppl.4). – P. 1-64.
81. Bruunsgaard H. Elderly humans show prolonged in vivo inflammatory activity
during pneumococcal infections / H. Bruunsgaard, P. Skinhoy, J. Qvist [et al.] // J.
Infect. Dis. – 1999. – Vol. 180. – P. 551-554.
82. Cassiere H.A. Community- acquired pneumonia / H.A. Cassiere, M.S.
Niederman // Dis. Mon. – 1998. - № 44 (11). – Р. 613-675.